Triglycerides HDL
Clinical evaluation of combined lab parameters.

A Triglycerides/HDL cholesterol ratio above 3 is strongly associated with an increased risk of cardiovascular disease and insulin resistance. This condition often indicates a lipid profile known as atherogenic dyslipidemia and can be a significant indicator of metabolic syndrome.
| Combination Status | Possible Clinical Significance | Recommended Physician Action |
|---|---|---|
| High Triglycerides, Low HDL (Ratio > 3) | High cardiovascular risk, insulin resistance, metabolic syndrome, atherogenic dyslipidemia. Increase in small, dense LDL particles. | Detailed metabolic evaluation (fasting glucose, HbA1c, insulin), lifestyle modifications (diet, exercise, weight management), assessment for pharmacotherapy if necessary. |
| High Triglycerides, Normal HDL (Ratio between 2-3) | Increased cardiovascular risk, but milder than ratio >3. Onset of insulin resistance or mild metabolic dysfunction. | Emphasis on lifestyle changes, detailed examination of other risk factors (blood pressure, obesity, family history), and regular follow-up. |
| Normal Triglycerides, Low HDL (Ratio between 1-2, due to low HDL) | Reduced protective effect of HDL, increased cardiovascular risk. Genetic predisposition or lifestyle factors (sedentary lifestyle, smoking) may be influential. | Investigation of specific causes of low HDL, lifestyle interventions, and general cardiovascular risk management. |
| Normal Triglycerides, Normal HDL (Ratio < 2) | Generally a low cardiovascular risk profile. Optimal lipid balance. | Routine health check-ups, continuation of healthy lifestyle recommendations. |
Clinical Rationale
The Triglycerides/HDL ratio is considered a more sensitive indicator of cardiovascular risk than traditional lipid parameters (total cholesterol, LDL cholesterol). A high ratio often reflects insulin resistance. Insulin resistance increases triglyceride synthesis in the liver while impairing HDL maturation and its capacity to transport cholesterol back from tissues to the liver. This leads to an increase in small, dense LDL particles (considered more atherogenic) and a decrease in HDL particles in circulation. Even if individual triglyceride or HDL levels are within normal limits, a high ratio can indicate underlying metabolic dysfunction and increased risk. Genetic predispositions, lifestyle factors (high-carbohydrate diet, sedentary lifestyle, obesity), and certain endocrine disorders can also contribute to an elevated ratio.
Which Medical Specialty Should Be Consulted?
If the Triglycerides/HDL ratio is high, an Internal Medicine specialist should be consulted first. If necessary, based on the physician's evaluation, referrals may be made to Cardiology (heart health) or Endocrinology (metabolic and hormonal disorders) specialists. These specialists will thoroughly investigate the underlying causes of the condition and develop a personalized treatment plan.
Why is the Triglycerides/HDL ratio more important than individual values?
This ratio is considered a better indicator of insulin resistance and metabolic syndrome. It provides a more comprehensive assessment of cardiovascular risk by reflecting the atherogenic dyslipidemia profile (high triglycerides, low HDL, small dense LDL).
What can be done to lower this ratio?
Lifestyle changes are fundamental: a low-glycemic index diet, poor in refined carbohydrates and sugar, regular physical activity, maintaining an ideal body weight, and quitting smoking. Under medical supervision, omega-3 supplements or lipid-lowering medications may also be considered.
If my Triglycerides/HDL ratio is high, does it mean I will definitely have a heart attack?
No, this ratio is a risk indicator, not a definitive diagnosis. A high ratio indicates an increased risk but does not mean you will definitely have a heart attack. Other factors (blood pressure, diabetes, smoking, family history) and physician evaluation are essential for a general cardiovascular risk assessment.
- World Health Organization (WHO) Laboratory Guidelines (2023)
- Turkish Clinical Biochemistry Association Reference Standards
General information only; not diagnosis or treatment. Review your results with your clinician.


